Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05243966 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Myriad™ Augmented Soft Tissue Reconstruction Registry

Study acronym: MASTRR
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 13 to 15v14
  2. Study sites: 12 to 13v13
  3. Study sites: 11 to 12v12
  4. Study sites: 10 to 11v11
  5. Enrollment target: 300 to 800
    • Primary completion date: Jan 2025 to Jan 2028
    • Study completion date: Jan 2026 to Jan 2029
    • Site details revised at 1 of 10 sites
    v10
Show 8 earlier versionsHide 8 earlier versions
  1. Re-verified, no change to tracked fieldsv9
  2. Study sites: 6 to 10v8
  3. Study sites: 5 to 6v7
  4. Study sites: 4 to 5v6
  5. Study sites: 3 to 4v5
  6. Site contacts updated at 1 of 3 sitesv4
  7. Study sites: 1 to 3v3
  8. Study description revised
    • Study title expanded, about 3 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll participants who are undergoing a surgical procedure, where the attending physician will use Myriad™ as part of the surgical intervention.
Trial Details
NCT Number NCT05243966
Lead Sponsor Aroa Biosurgery Limited
Conditions
(from sponsor)		 Abdominal Wound Dehiscence, Necrotizing Soft Tissue Infection, Lower Extremity Wound, Pilonidal Sinus, Anal Fistula, Hidradenitis Suppurativa, Pressure Injury
Related terms Hidradenitis Suppurativa, Pilonidal Sinus, Pressure Ulcer, Rectal Fistula
Enrollment 800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov